J&J and Cook: Win a Little, Lose a Little
Some Johnson & Johnson supporters are gloating publicly over the company's recent settlement of its litigation against Cook Group Inc. for violating patents on its Palmaz-Schatz coronary stent. J&J announced in early February that it agreed to license rights to the patent to Cook in exchange for royalty payments; terms were not disclosed. J&J's release called the settlement "amicable." But the outcome is actually far from black and white.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.